# ReCode Therapeutics

**Canonical:** https://apis.io/providers/recode-therapeutics/  
**Website:** https://recodetx.com/  
**APIs profiled:** 7

ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California with operations in Dallas, Texas, founded in 2015 out of research at UT Southwestern. Its Selective Organ Targeting (SORT) lipid nanoparticle platform is a delivery technology that directs mRNA and gene-correction payloads to organs, tissues and cells beyond the liver — the constraint that has limited genetic medicines to date — with redosing capability. Its lead programmes are RCT1100, an inhaled DNAI1 mRNA therapy for primary ciliary dyskinesia which has reported first-ever proof of activity in PCD patients, and RCT2100, an inhaled CFTR mRNA therapy for cystic fibrosis now in a Phase 2 combination trial with ivacaftor; both hold U.S. FDA Orphan Drug designation. The company collaborates with Intellia Therapeutics on CRISPR-based gene correction for cystic fibrosis, is funded in part by the Cystic Fibrosis Foundation, and has raised over $260 million in Series B financing. ReCode Therapeutics runs no developer program and publishes no product API, developer portal or API documentation; the only machine-readable surface reachable without credentials is the WordPress REST content API behind recodetx.com, catalogued here alongside the llms.txt the site publishes.

## Kin Score — 30.7 / 100 (thin)

Scored 2026-08-12 under rubric 0.11.0. Trend: flat (+0.0 from 30.7).

| Facet | Score |
|---|---|
| Discoverability | 81.5 |
| Contract Quality | 57.4 |
| Governance | 11.5 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 12.5 |
| Commercial Clarity | 21.1 |

Regulatory layer — **Health**: 31.3 (matched via tags).

## Agent readiness — 30.0 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | yes |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | yes |
| Idempotency | no |
| Error Semantics | documented |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | derived |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## APIs (7)

- **ReCode Therapeutics Content API** — Press releases, publications, corporate pages and site-specific custom post types.
- **ReCode Therapeutics Discovery API** — Route index and namespace metadata the install publishes about itself.
- **ReCode Therapeutics Embed API** — oEmbed 1.0 provider endpoint for recodetx.com URLs.
- **ReCode Therapeutics Media API** — The media library — images, PDFs, posters and decks attached to the site.
- **ReCode Therapeutics People API** — Author records. Personal data — read the x-personal-data annotation before use.
- **ReCode Therapeutics Search API** — Cross-content search across every REST-exposed post type.
- **ReCode Therapeutics Taxonomy API** — Categories, tags, and the registered type/status/taxonomy descriptors.

## Security (2)

- **Recode Therapeutics Authentication** — 0 schemes
- **Recode Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, genetic-medicines, biotechnology, biopharmaceuticals, mrna, gene-correction, lipid-nanoparticles, drug-delivery, rare-disease, cystic-fibrosis, primary-ciliary-dyskinesia, clinical-trials, life-sciences, content-api

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/recode-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.